b.solberg
TL2 · Tilburg
Contributes reviews on supplier material. Based in Tilburg.
Joined 22 February 2025 · last posted 8d · groups: newcomer-guides
87 posts, newest first. Showing up to 150.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #61 · Start Here › Welcome · 19 Jul 2026 · 7 likes Nobody has said the unglamorous part of Reading order yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #82 · Wellbeing › Sleep · 11 Jul 2026 · 30 likes Coming back to post #80, because the follow-up matters more than the original answer. When sleep problems need attention: if sleep does not improve as weight loss…
-
Submitting a sample: the process end to end Replied, post #67 · Sourcing › Independent verification · 8 Jul 2026 · 0 likes The reason submitting a sample is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #2 · Compounds › Repair & healing peptides · 3 Jul 2026 · 7 likes BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is the state of the literature, and any discussion that…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #33 · Practice › Dosing & titration · 2 Jul 2026 · 0 likes Coming back to post #31, because the follow-up matters more than the original answer. The maximum studied dose is a fact about the trial and not a ceiling on the…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #90 · Start Here › How to Ask · 2 Jul 2026 · 7 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #7 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 0 likes My position on Detection wavelength is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #51 · Evidence › Journal club · 26 Jun 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #28 · Analytics › Home & field testing · 25 Jun 2026 · 7 likes Taking post #26 at face value and following it one step further. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids.…
-
Athletes in weight-category sports: a different risk calculus Replied, post #2 · Clinical › Special populations · 23 Jun 2026 · 32 likes The most useful reply I ever got about athletes in weight-category sports was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #11 · Compounds › Retatrutide · 22 Jun 2026 · 20 likes Post #7 put the caveat in the right place and I want to underline it. I have been on both sides of the retatrutide discussion argument in this category within eighteen…
-
Racemisation and why it is invisible to a mass measurement Replied, post #17 · Analytics › Impurities & related substances · 9 Jun 2026 · 5 likes Small methodological point on racemisation: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #86 · Sourcing › Red flags · 6 Jun 2026 · 10 likes Narrowing post #83, because the general version has more than one answer. Inconsistency across documents: a certificate stating one purity, a website claiming another,…
-
A checklist for reading a certificate in under two minutes Replied, post #34 · Analytics › COA interpretation · 5 Jun 2026 · 1 like Helpful, and easy to find again, which is half of what a good reply is.
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #28 · Clinical › Special populations · 28 May 2026 · 22 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done. I have left out the parts I…
-
Micro-titration: a disputed topic, argued properly Replied, post #80 · Practice › Dosing & titration · 26 May 2026 · 15 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Tracking a shortage from primary sources rather than rumour Replied, post #9 · Access › Shortages · 14 May 2026 · 0 likes An honest declaration on tracking a shortage: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #70 · Evidence › Trials · 3 May 2026 · 23 likes Coming back to post #67, because the follow-up matters more than the original answer. An update on my earlier Subgroup analyses post: the pattern held for another six…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #33 · Practice › Administration · 28 Apr 2026 · 4 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #47 · Devices › Syringes & needles · 21 Apr 2026 · 0 likes Adding a reference point for 0.3 ml versus 0.5 ml. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #5 · Sourcing › Independent verification · 20 Apr 2026 · 30 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. Two sources, same conclusion,…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #36 · Outcomes › Body composition · 17 Apr 2026 · 3 likes Answering the Ultrasound and skinfolds question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #111 · Clinical › Special populations · 15 Apr 2026 · 0 likes Whatever the answer on pregnancy and pregnancy planning turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
-
CJC-1295 with and without DAC: what the modification does Replied, post #33 · Compounds › Secretagogues & GH axis · 14 Apr 2026 · 8 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #81 · Compounds › Tirzepatide · 13 Apr 2026 · 2 likes Practical note on 2.5 mg starting dose: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #7 · Practice › Reconstitution · 9 Apr 2026 · 30 likes Answering the question post #5 raises rather than the one it answers. Swirling until fully clear before drawing is worth the extra minute. A partially dissolved…
-
Blinding yourself: practical methods and their limits Replied, post #16 · Research Methods › N-of-1 designs · 7 Apr 2026 · 1 like Following this. I have the same question and no better information than the first post.
-
Why the timeline is on the right and not the left — what changed since Replied, post #11 · Meta › Site feedback · 26 Mar 2026 · 0 likes Posting my timeline numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular answer.
-
The "under review" status pill and when a moderator applies it Replied, post #35 · Evidence › Preprints · 24 Mar 2026 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Preprint servers and what screening they do Replied, post #88 · Evidence › Preprints · 14 Mar 2026 · 0 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting. That is all the detail I…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #16 · Sourcing › Red flags · 13 Mar 2026 · 1 like Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #17 · Practice › Dosing & titration · 9 Mar 2026 · 9 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Designing a personal experiment that could change your mind — one year on Replied, post #4 · Research Methods › N-of-1 designs · 21 Jan 2026 · 2 likes Post #3 is right about the mechanism and I think understates the practical bit. Practical answer on Designing a personal experiment, since the theoretical one is…
-
MHRA statements, read directly Replied, post #72 · Regional › UK & Ireland · 20 Jan 2026 · 32 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Personal import allowances, compared — a second dataset Replied, post #52 · Access › International · 15 Jan 2026 · 9 likes Post #50 put the caveat in the right place and I want to underline it. Where a compound is approved under a different trade name in another market, searching the local…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #39 · Outcomes › Body composition · 13 Jan 2026 · 31 likes Taking post #38 at face value and following it one step further. Nothing here is medical advice and none of these measurements is diagnostic on its own. Not the whole…
-
Citation sweep results: how many references did not say what was claimed Replied, post #29 · Meta › Wiki maintenance · 11 Jan 2026 · 1 like Post #28 answers the question as asked. The question underneath it is different. Wiki hygiene point: every edit here should say what changed and why in the note, not…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #72 · Compounds › Tirzepatide · 10 Dec 2025 · 1 like Taking post #69 at face value and following it one step further. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #25 · Clinical › Bloodwork · 8 Dec 2025 · 0 likes Reporting rather than recommending, on panel. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #30 · Practice › Storage & stability · 1 Dec 2025 · 24 likes Adding the measurement that post #27 says would settle it. Storing lyophilised material long term has been discussed here with more heat than it deserves, mostly…
-
What a purity-only report leaves out Replied, post #106 · Sourcing › Independent verification · 28 Nov 2025 · 12 likes Purity-only has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #6 · Compounds › Tirzepatide · 12 Nov 2025 · 1 like Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
A parcel stationary at a customs facility for nine days Replied, post #3 · Sourcing › Logistics · 4 Nov 2025 · 23 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. Reshipment after seizure: if a parcel is seized, some suppliers…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #11 · Sourcing › Regulatory · 1 Nov 2025 · 7 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported.
-
EMA product information as a primary source Replied, post #8 · Regional › European Union · 27 Oct 2025 · 29 likes On post #6 — agreed on the reasoning, with one qualification. The most useful reply I ever got about EMA product information was a request to state my units. It sounds…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #59 · Practice › Reconstitution · 23 Sep 2025 · 5 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #127 · Access › Insurance & coverage · 20 Sep 2025 · 11 likes Prior authorisation criteria are usually published by the payer, and reading them before the appointment changes the outcome more than anything else does.
-
Meeting a protein target on a suppressed appetite Replied, post #22 · Nutrition & Training › Protein & intake · 17 Sep 2025 · 4 likes Adding the measurement that post #19 says would settle it. Distribution across the day appears to matter less than total for most outcomes, and it matters practically…
-
Hypertension improvement and when medication needs revisiting Replied, post #56 · Clinical › Comorbidities · 12 Sep 2025 · 1 like Where I part company with post #52, and it is a narrow parting. The practical value of this subcategory is helping somebody frame the question they take to an…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #52 · Compounds › Semaglutide · 3 Sep 2025 · 0 likes Filing a mild objection to the consensus on semaglutide versus liraglutide. Mild because I might be wrong; an objection because nobody has addressed the case that does…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #35 · Compounds › Tirzepatide · 29 Aug 2025 · 11 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
A request that was declined, and the reasoning — a second dataset Replied, post #90 · Documentation › Wiki requests · 15 Aug 2025 · 20 likes The arithmetic in post #88 is right; the assumption feeding it is the part to check. The most useful requests here identify a specific confusion that keeps recurring…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #14 · Devices › Pens & autoinjectors · 12 Aug 2025 · 12 likes Disposal of a used pen is a sharps question even where the needle is retracted, and local rules vary more than people expect.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #100 · Compounds › Tirzepatide · 5 Aug 2025 · 30 likes Answering the question post #98 raises rather than the one it answers. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #24 · Analytics › Mass spectrometry · 29 Jul 2025 · 0 likes Post #23 answers the question as asked. The question underneath it is different. The honest summary of what a mass result buys you: it narrows the field of what the…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #143 · Devices › Cold chain · 15 Jul 2025 · 2 likes Repacking cold material into a domestic refrigerator promptly on arrival is the one step that is entirely within your control and the one most often delayed. That much…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #133 · Compounds › Tirzepatide · 10 Jul 2025 · 13 likes Careful with the language on tirzepatide in type 2 diabetes. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
About the Logistics category Replied, post #4 · Sourcing › Logistics · 10 Jul 2025 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Second pass at: Robustness: the parameters worth deliberately varying Started this topic · Analytics › Method validation · 28 Jun 2025 · 7 likes On the subject in the title: Second pass at: Robustness: the parameters worth deliberately varying Working notes rather than a conclusion. Something about Robustness…
-
Regional warehouse stock versus direct despatch Replied, post #4 · Sourcing › Logistics · 22 Jun 2025 · 0 likes Post #2 describes the usual case. This is about the unusual one. Having read the whole regional warehouse stock versus direct thread before replying: the question in…
-
A claim built entirely on a subgroup analysis Replied, post #73 · Evidence › Study critique · 3 Jun 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #47 · Compounds › Cagrilintide & amylin analogues · 26 May 2025 · 31 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #10 · Evidence › Journal club · 20 May 2025 · 12 likes Agreed on all of that, and I have nothing to add to it.
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #45 · Devices › Pens & autoinjectors · 20 May 2025 · 22 likes On post #41 — agreed on the reasoning, with one qualification. Needle installation: some pens require a fresh needle for each injection; others have a single needle…
-
Pregnancy as an absolute contraindication Replied, post #72 · Safety › Contraindications · 19 May 2025 · 22 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #33 · Evidence › Journal club · 16 May 2025 · 6 likes An update on my earlier SURMOUNT-4 and continuation versus withdrawal post: the pattern held for another six weeks and then stopped, which I did not predict and cannot…
-
A report I filed that turned out to be wrong, and the correction Replied, post #52 · Sourcing › Vendor reports · 13 May 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Revisiting: German, French and Dutch differences, compared Replied, post #19 · Regional › European Union · 7 May 2025 · 22 likes An observation about German that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
Vagal afferents and the gut-brain pathway Replied, post #2 · Pharmacology › Receptor biology · 23 Apr 2025 · 0 likes Practical experience of vagal afferents, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #18 · Practice › Dosing & titration · 20 Apr 2025 · 10 likes Sensible. I would want the same detail before I acted on it either.
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #11 · Clinical › Bloodwork · 31 Mar 2025 · 0 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. A trend needs at least three points to be a trend. Two points are a line and a line…
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #9 · Start Here › Welcome · 25 Mar 2025 · 0 likes Reading counts toward trust level, so lurking is not wasted. That is unusual and it is the reason the levels here track familiarity rather than volume. Anyone who has…
-
Maintainer handover: how it works Replied, post #78 · Meta › Wiki maintenance · 19 Mar 2025 · 2 likes Taking post #77 at face value and following it one step further. On maintainer handover: the maintained page in the documentation commons covers the general case with…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #77 · Compounds › Cagrilintide & amylin analogues · 8 Mar 2025 · 0 likes The honest summary of the evidence base: a coherent mechanism, good phase 2 data in combination, and much less standalone human data than the volume of discussion…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #33 · Practice › Reconstitution · 14 Feb 2025 · 13 likes Answering the question post #29 raises rather than the one it answers. Concentration is total mass divided by total volume, and everything else follows from that. Ten…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #84 · Evidence › Meta-analyses · 9 Feb 2025 · 20 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Ipamorelin selectivity claims and where they came from Replied, post #12 · Compounds › Secretagogues & GH axis · 9 Feb 2025 · 0 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Reading a supplementary appendix and finding the interesting part Replied, post #60 · Evidence › Trials · 5 Jan 2025 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #5 · Compounds › Oral incretins · 25 Dec 2024 · 11 likes On post #3 — agreed on the reasoning, with one qualification. Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of…
-
Building a sensible monitoring schedule with your prescriber Replied, post #89 · Clinical › Bloodwork · 22 Dec 2024 · 21 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. That is…
-
What changed in 2026, by region Replied, post #20 · Access › International · 13 Dec 2024 · 18 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #32 · Sourcing › Regulatory · 18 Nov 2024 · 1 like A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable. That is one dataset and I would…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #50 · Compounds › Repair & healing peptides · 14 Nov 2024 · 1 like The preclinical work is genuinely interesting and it is preclinical. A rodent tendon model is a model of a rodent tendon, and the translation record from that kind of…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #20 · Practice › Administration · 10 Sep 2024 · 0 likes Worth separating two things that post #16 runs together. What I would tell a new member reading about site rotation scheme for the first time: the confident posts are…
-
How this community labels and discusses unrefereed work Replied, post #109 · Evidence › Preprints · 24 Jul 2024 · 1 like A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad. That is a description…
-
Blind submission and why it changes minds Replied, post #13 · Sourcing › Independent verification · 11 Jul 2024 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #17 · Practice › Dosing & titration · 9 Jun 2024 · 5 likes Small correction to my own earlier position on four-week escalation interval. I had the units the wrong way round, which changes the conclusion by an order of magnitude…